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Abstract The transcription of the human tenaein-C (TN-C) 
gene is directed by a single promoter. Here we demonstrate, in 
transiently transfected cells, that two distinct regions of the un- 
translated 179 bp-long exon 1 play antagonistic roles in transcrip- 
tional regulation: bases from 1 to 20 strongly increase the tran- 
scription of the reporter gene CAT directed by the human TN-C 
gene promoter, while bases from 79 to 179 significantly reduce 
this activation. 
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I. Introduction 
Human tenascin-C (TN-C) is an extracellular matrix 
glycoprotein composed of six similar subunits joined together 
at their NH+-terminus by disulfide bonds [1-4]. During devel- 
opment of various organs, human TN-C displays a 'site- and 
time-restricted' expression which is especially evident in the 
developing central nervous system [5]. In adult tissues, human 
TN-C expression transiently increases during wound healing 
[1 3] and neo-expression or a dramatic increase in its expres- 
sion, as well as a striking modification in its RNA alternative 
splicing, have been reported in several tumors [4,6]. Further- 
more, fetal calf serum and cytokines induce human TN-C ex- 
pression in cultured cells [1 3]. 
The gene encoding human TN-C has been cloned, its struc- 
ture elucidated [7,8], and a preliminary characterization of the 
sequences responsible for its transcription has been performed 
[7]. Human TN-C gene transcription is directed by a single 
promoter,  and a relatively large intron (-> 18 kb) separates the 
first untranslated exon (exon 1,179 bp long) from exon 2 which 
contains the translation initiation [7,9]. By transient ransfec- 
tion of cells producing and non producing human TN-C, we 
previously demonstrated that the presence of the complete xon 
1 plus a part of the first intron of the human TN-C gene 
strikingly enhances the chloramphenicol  acetyl transferase 
(CAT) gene transcription directed by the human TN-C pro- 
moter in human TN-C producing SK-MEL-28 melanoma cells. 
Here we report on the role played by different regions of the 
first exon of the gene in transcriptional regulation. 
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2. Materials and methods 
2,1. Cell lines, human TN-C promoter-(',4T eonslructs, and DNA 
trun.s'lbctioH 
SK-MEL-28 human melanoma, U87-MG human glioblastoma, 
hamster lnR l-G9, and mouse NIH 3T3 cells were cultured as in [7]. The 
functiomd activity of the human TN-C gene transcriptional regulatory 
regions was analyzed utilizing the previously [7] described recombinant 
vectors pTN220CAT (from -220 to +79, here more precisely called 
pTN220 + 79/CAT) and pTN650CAT (from -65(/to +79, here referred 
to as pTN650 + 79/CAT) and by constructing two series of new vectors 
in which different regions of the human TN-C promoter and the exon 
1, obtained by PCR (using U1Tma DNA polymerase from Perkin- 
Elmer, Norwalk, CT), were cloned into the polylinker of pCAT Basic 
(Promega, Madison, WI) [7]. In the tirst series, the 24-mer 5' primers 
had a 5' Pstl restriction site and initiated at base -220 [7]. The 28-met 
3' primers, starting in its 5' end at bases I, 20, and 179 of the human 
TN gene, respectively, and containing a Xhal restriction site at its 5' 
end, were used. In the second series, the 26-mcr 5' primers had a 5' Pstl 
restriction site and initiated at base -650 [7]. The 28-mer 3' primers 
utilized were the same described above. The fragments thus obtained 
were cloned inlo pCAT-Basic vector, thereby creating the constructs 
pTN220/CAT, pTN220 + 20/CAT, pTN220 + 179/CAT, pTN650/ 
CAT, pTN650 + 20/CAT, and pTN650 + 179/CAT, respectively. The 
promoterless pCAT-Basic and a construct in which 220 bp of the 
promoter and 79 bp of the exon 1 were cloned into pCAT-Basic with 
opposite orientation in respect to the transcription initiation site 
(pTNRev-CATI were the negative contrnls. 
Transient transfection by either the calcium phosphate or the DEAE- 
Dextran technique, CAT, and fl-galactosidase activity assays were car- 
ried out as reported in [7]. DNA sequence analysis and alignements 
were pert\3rmed using the GeneJockey (Biosoft, Cambridge, UK) and 
GeneWorks 2.3.1 (IntelliGenetics Inc.+ Mountain View, ('A) softwares 
for Macintosh Power PC computers. 
2.2. Reverse transcription and PCR amplilication +?/'total RNA 
( R T/PCR 
Total RNA was prepared from U87-MG and InRI-G9 cells trans- 
fected with the different CAT plasmids by the guanidine/cesium chlo- 
ride method [Ill]. RNA preparations were subjected to a 30 min treat- 
mcnt with RNAse-free DNAse (RQ1 by Promega). The reverse 
transcription and the amplification by polymerase chain reaction (RT/ 
PCR) of the DNAse-treated RNA was performed as described in [11]. 
CAT scquences were amplified using the following primers: primer 
CAT1 5'-TCA•TGTACCTATAACCAGACC-3' (from base 2401 to 
base 2422 in the plasmid pCAT-Basic) and primer (',4T2 5'-AGGTT- 
TTCACCGTAACACGCCA-3' (from base 2706 to base 2685 in the 
plasmid pCAT-Basic) giving an amplification product of 306 bp. The 
MHC class II-related gene fl2-microglobulin was used as an internal 
control to normalize CAT transcript levels measured by RT/PCR as 
previously detailed [11]. In order to identify possible amplification 
products generated by contaminating genomic or plasmid DNA, we 
subjected RNA preparations to PCR utilizing two sets of primers de- 
signed to amplify either the region from -220 to I of the human TN-(' 
gene or the CAT gene. The analysis and quantitation of RT/PCR 
products was performed as described in [I 1]. To optimize RT/PCR, 
preliminary dose- response xperiments were performed to determine 
the range of RNA concentrations at which PCR amplification was 
linear tot" each target molecule in either U87-MG or InR1-G9 cells as 
described in [11]. 0.5 ng and 250 ng of RNA of both cell lines were used 
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in RT/PCR experiments for quantification of both CAT and fl2-mi- 
croglobulin, respectively. 
3. Results and discussion 
Aim of this study was to investigate the transcriptional role 
of the human TN-C exon 1. 
Alignment of human TN-C exon 1 with either rat or chicken 
exon 1 sequences reveals overall identities of 74% and 50%, 
respectively. As presented in Fig. 1A and E, a region with the 
highest homology between human and mouse exon 1 is present 
in the first 50 bp of exon 1. Similarly, human and chicken exon 
1 sequences, although more discordant, present the highest 
homology in the 45 bp closest o the transcription start site (Fig. 
1, panel B). However, the dot matrix plots presented in panels 
C and D of Fig. 1 clearly indicate that the homology between 
human, mouse, and chicken is significantly higher in TN-C 
exon 2 than in exon 1. This high level of homology extends over 
the entire coding sequences (data not shown). Copertino et al. 
[12], on the basis of sequence comparison between the mouse 
< 
A 
• L '. 
.•.. 
20 
4O 
60 
100 ~ 
" 120 
• 140 
160 
'20 '40 '60' 80 '100'120'140'160 
MOUSE 
C 
B 
,. " ~iI( 
20 
40 
60 
80 
i 100 
: 120 
140 
160 
' 20 ' 40 ' 60 ' 80 '100 '120'140 '160 
CHICKEN 
D 
x, . .  
" \ \  
~\ , , '  
'50 
. i \  
'100 '150 '200 '250 
MOUSE 
50 
100 z 
- 150 
- 200 
- 250 
N . • 
. . \  
• '. • " . .  
\ .  
• . . . '  . . . , 
, . . ,  . 
50 '100 '150 '200 '250 
CHICKEN 
50 
100 
150 
200 
250 
E 
1 J~P~GC~,~.  GCCTGCCTAC TGTCACCCGC CTCTCCCGCG CGCAGATACA 
~e eee  eeeeee eee  eee  eeeeee eeeeee eee  eeeeee • 
1 GCCTGCCTAC TGTCACGCGT CTCTCCCGCG C ~  
HUMAN 
MOUSE 
CGCCCCCGCC TCC-GTGGGC ACAAAGGCAG CGCTGCTGGG GA-ACTCGGG 
• eee  eee  ee  eeeeee  eee  ee  ee  • eeeeee  • ee  • • 
CACCCTAGCC TCTGGTGGGC ACA- -GACAG TG- -GCTGGG AAGACGCTAG 
GGAACGC~2~ CGTGGGAAC-  CGCCGCAGCT CCACACTCCA GGTACTTCTT 
• • • • eeeeee  ee  • ee  • • eeee  • eee  • ee  • • eeeeeee*  
GGACCGCGCG CTTGGGAACT CGTTGTGGCT -TA-AC-CCA GGTACTTCTT 
• • eeo  ee  eee  • eeee  ee  • 
C-ACGGAGCT -GGT- - -GCA CCCA- - -GAG ACTTTGCTTT TCCCGACCTG 
179 
182 
Fig. 1. Similarities of the human, mouse, and chicken TN-C, exon 1 and exon 2. The sequences of the entire exons I (A and B) and of the most 5' 
300 bp of exons 2 (C and D) of TN-C genes were compared using a dot matrix program. In the matrix, each dot represents 7 identities per 10 
nucleotides. Regions of homology are indicated by slanted arrows• In panel E, the sequences of human [7] and mouse [12] TN-C genes are aligned. 
The dashed line indicates the region Si2 of the human exon 1 while the solid line covers the 'E-box'. 
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Fig. 2. Analysis of the the transcriptional properties of the human 
TN-C exon 1 by transient ransfection of CAT reporter plasmids in 
U87-MG and InRI-G9 cells. In panel A, the structure of the 5' region 
of the human TN-C gene as well as the transfected promoter/exon 
I-CAT plasmids are schematically represented. U87-MG human glio- 
blastoma (panel B) and InRI-G9 hamster glucagonoma (panel CI cells 
were transiently transfected with 12 fig of pRSV-CAT or each of the 
indicated recombinant plasmids and 2 ,ug of pCMV-fl-Gal using the 
calcium phosphate or the DEAE-Dextran technique, respectively (as 
detailed in section 2). 48 h after transfection, cells were harvested and 
CAT and fl-galactosidase activities in cell lysates were measured. Chlo- 
ramphenicol acetyltransferase activities were normalized taking into 
account fl-galactosidase activities measured in all the experiments. The 
average (_ + S. E. M.) of six independent experiments performed in dupli- 
cate for each cell line is presented. 
and the chicken TN-C gene promoters, postulated that con- 
served regions (such as the proximal promoter, -250 bp long) 
play a constant role throughout different species, while diver- 
gent regions imply species-specific temporal and spatial differ- 
ences in the gene expression pattern. 
To investigate whether different regions of human TN-C 
exon 1 display any specific transcriptional properties, a number 
of exon 1 deletion constructs were cloned into a CAT expres- 
sion vector, and sequenced to confirm their identity (see section 
2 and Fig. 2). The resulting plasmids, together with pCMV-fl- 
Gal as an internal control for transfection efficiency, were 
transiently transfected into U87-MG human glioblastoma, 
SK-MEL-28 human melanoma, InRI -G9 hamster glucagon- 
oma cells, and in NIH 3T3 mouse fibroblasts. Cell lysates were 
then assayed lbr both CAT and fl-galactosidase activities. As 
illustrated in Fig. 2, a vector in which CAT expression is di- 
rected by the 220 bp immediately 5'to the putative transcription 
start site is transcriptionally active in both human and rodent 
cell lines (t¥om 5- to 10-fold over the negative control pTNRev/ 
CAT). The addition to this proximal promoter of 20 bp of the 
exon 1 strongly increases the reporter gene expression in human 
and rodent cells (Fig. 2 and data not shown). This finding is in 
agreement with data reported by Pan and Greenblatt [13]. 
These authors demonstrated that mutations in nucleotides 
close to the transcription start site (either at its 5' or at its 3' 
side) influence the transcript elongation by affecting the inter- 
action with selected components of the general transcription 
machinery [13]. 
The presence of a further 59 bp of exon 1 (pTN220 + 79/ 
CAT) did not affect the ability of the human TN-C promoter 
to drive CAT gene transcription in both human and rodent cell 
lines (Fig. 2 and data not shown). The construct pTN220 + 179/ 
CAT was 60% less efficient than pTN220 + 20/CAT or 
pTN220 + 79/CAT to drive the expression of the reporter gene 
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Fig. 3. RT/PCR analysis of CAT and fl2-microglobulin transcripts in 
U87-MG and lnRI-G9 cells. Subconfluent cultures of U87-MG and 
InRI-G9 cells were transiently transfected with the lk~llowing CAT 
recombinant expression vectors using the calcium phosphate or the 
DEAE-Dextran technique, respectively: none (lanes 1 and 7 in A); 
pTNRev/CAT (lanes 2, and 8 in A; I and 6 in B); pTN220/CAT (lanes 
3, and 9 in A; 2 and 7 in B), pTN220 + 20/CAT (lanes 4, and 10 in A 
3 and 8 in B); pTN220 + 79/CAT (lanes 5, and 11 in A; 4 and 9 in B), 
pTN220 + 179/CAT (lanes 6, and 12 in A; 5 and 10 in B). After 48 h, 
cultures were extensively washed with PBS and harvested. Total RNA 
was prepared and subjected to RT/PCR as detailed in section 2. RT/ 
PCR products were electrophoresed and agarose gels stained with 
ethidium bromide and photographed. The bands corresponding to 
CAT and fl:microglobulin transcripts inethidium bromide-stained gels 
were densitometrically scanned and the relative absorbances (expressed 
in arbitrary units) of two independent experiments (including that pre- 
sented in the figure) are: CAT 9.0 (lane 2), 8.6 (lane 3), 25.2 (lane 4), 
23.1 (lane 5), 20.4 (lane 6), 18.5 (lane 8), 43.7 (lane 9), 99.5 (lane 101, 
111.2 (lane 11 ). 25.5 (lane 12); fl2-microglobulin 63.4 (lane I ), 29.0 (lane 
2), 51.0 (lane 3), 38.1 (lane 4), 15.5 (lane 5), 98.4 (lane 6), 69.2 (lane 7), 
124.0 (lane 8),82.0 (lane 9), 99.1 (lane 10). 
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Fig. 4. The transcriptional properties of the human TN-C exon 1, analyzed by transient transfection ofCAT reporter plasmids in U87-MG, do not 
depend on the size of TN-C promoter. On the left, the structure of the transfected promoter/exon I-CAT plasmids are schematically represented. 
U87-MG human glioblastoma cells were transiently transfected with 12/~g of each of the indicated recombinant plasmids and 2/zg of pCMV-fl-Gal 
using the the calcium phosphate technique, respectively (as detailed in section 2). 48 h after transfection, cells were harvested and CAT and 
fl-galactosidase activities in cell lysates were measured. Chloramphenicol acetyltransferase ctivities were normalized taking into account fl-galacto- 
sidase activities measured inall the experiments. The average (+ S.E.M.) of four independent experiments performed induplicate for each cell line 
is presented. 
in human U87-MG (Fig. 2) and SK-MEL-28 (not shown) cells. 
However, the transcriptional ctivity of pTN220 + 179/CAT 
was similar to that of pTN220 + 20/CAT and pTN220 + 79/ 
CAT constructs in transfected hamster InR1-G9 cells (Fig. 2) 
and murine NIH 3T3 cells (not shown). These data suggest that 
the regulatory element(s) interacting with the exon 1 sequence 
from +79 to +179 may be species-specific. This hypothesis i
supported by the observation of the low sequence homology 
between different species in this region of TN-C exon 1 
(Fig. 1 ). 
The possibility existed that the regulatory elements present 
in the sequence from 79 to 179 of the human TN-C exon 1 were 
transcriptionally effective only in the context of the 220 bp-long 
proximal promoter. To verify this hypothesis, we transiently 
transfected cells with CAT expression vectors containing 650 
bp of the human TN-C promoter instead of 220 bp. As depicted 
in Fig. 4, this set of vectors also revealed that the regions from 
1 to 20 ('enhancer 1'; Enl) and from 79 to 179 ('silencer 2'; Si2) 
of exon 1 exert positive and negative actions on transcription, 
respectively in human U87-MG and SK-MEL-28 cells (not 
shown). As expected on the basis of our previous results [7], the 
transcriptional activity of the 650 bp promoter constructs was 
remarkably lower than the activity of 220 bp promoter con- 
structs. 
The location of elements Enl (nucleotides 1 20 in exon 1) 
and Si2 (nucleotides 79-179 in exon 1) in a transcribed region 
of the gene raises the possibility that they regulate gene expres- 
sion at the level of translation rather than transcription. There- 
fore, we determined through quantitative RT/PCR the levels of 
CAT mRNA in transiently transfected cells. As presented in 
Fig. 3, the RT/PCR results were parallel to those obtained from 
the CAT assays. This finding indicates that the two regulatory 
elements in the human TN-C exon 1 act by regulating the 
transcription of the reporter gene CAT. 
The sequence analysis of exon 1 revealed, at nucleotides 
106-111, the presence of an 'E box' (CACGTG), a previously 
reported consensus binding site for proteins belonging to the 
basic helix-loop-helix family of transcription factors (such as 
Myc and Max) [14,15]. It is noteworthy that the sequence ho- 
mology between human TN-C exon 1 and Myc-Max DNA 
binding sites, like those detectable in prothymosin-a and in 
ornithine decarboxylase g nes [16,17], extends ignificantly up- 
stream and downstream of the 'E box' (Fig. IE). In a recent 
paper Shor et al. reported that two Myc-Max binding motifs 
constitute the attenuator element Attenuator 1 responsible for 
RNA elongation arrest in the murine ornithine decarboxylase 
gene [18]. However, the 'E-box' is not present in the sequence 
of mouse TN-C exon 1 [12]. This observation suggests that this 
element is not important for TN-C transcriptional regulation 
or, alternatively, that differences exist between the regulatory 
mechanisms responsible for TN-C gene transcription i  the two 
species. 
Transcribed DNA sequences are usually excluded from re- 
porter constructs used to characterize promoters. This leads to 
the possibility that transcriptional regulatory elements present 
in exons of several genes go undetected. In the last few years, 
a growing number of examples of exonic and intronic transcrip- 
tional regulatory sequences, either positive [19-23] or negative 
[21 26], have been reported. 
Both chicken and mouse tenascin-C gene transcription has 
been postulated to be negatively regulated by sequences placed 
upstream to the approximately 250 bp long promoter [12,27]. 
These results are consistent with our previous observations in 
the human gene [7]. The present results demonstrate that addi- 
tional positive and negative lements are present in the transci- 
bed region of the human TN-C gene. 
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